Scientists target Cancer's food supply in new treatment trial
NCT ID NCT03449901
Summary
This study tested whether adding a new drug called ADI-PEG20 to standard chemotherapy could better control advanced soft tissue sarcomas and some other cancers. The new drug works by cutting off a nutrient some cancer cells need to survive, potentially making the chemotherapy more effective. The trial involved 98 people with cancers that had spread or couldn't be removed by surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Sarcoma Oncology Center
Santa Monica, California, 90403, United States
-
Stanford Medicine
Palo Alto, California, 94304, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.